Competidores
Simbolo bursátil | Precio | Pronóstico 1A | Pronóstico 2A | Cap. Mercado | Div Yld | Tasa de crecimiento |
---|---|---|---|---|---|---|
NYSE:TEVA
Teva Pharmaceutical Industries
|
16.29 | -46.21% | -42.74% | 18,450.72 | 0% | -2.6% |
LSE:HIK
Hikma Pharmaceuticals PLC
|
19.78 | 25.31% | 38.17% | 4,424.39 | 2.86% | 10.04% |
NasdaqGS:AMPH
Amphastar Pharmaceuticals
|
43.48 | 226.92% | 260.8% | 2,085.6 | 0% | 73.69% |
NasdaqGM:SUPN
Supernus Pharmaceuticals
|
29.10 | 2.87% | 17.34% | 1,720.68 | 0% | -11.07% |
NasdaqGM:ANIP
ANI Pharmaceuticals
|
61.43 | -23.93% | -11.39% | 1,376.73 | 0% | -1.46% |
NasdaqGS:IRWD
Ironwood Pharmaceuticals
|
6.48 | -12.08% | 18.33% | 1,290.73 | 0% | 0% |
NasdaqGS:COLL
Collegium Pharmaceutical
|
32.47 | -16.33% | -9.24% | 1,238.24 | 0% | 114.17% |
NasdaqGS:PCRX
Pacira BioSciences
|
30.82 | 193.88% | 259.23% | 1,233.33 | 0% | 21.99% |
NasdaqGS:BDSI
BioDelivery Sciences International
|
5.59 | -13.16% | 13.85% | 577.05 | 0% | 58.11% |
NasdaqGM:AQST
Aquestive Therapeutics
|
3.11 | 0% | 0% | 307.71 | 0% | 0% |
NYSE:EBS
Emergent BioSolutions
|
5.55 | 33.09% | 174.9% | 229 | 0% | 0% |
NasdaqGS:ZVRA
Zevra Therapeutics
|
4.73 | 0% | 0% | 204.66 | 0% | 0% |
NasdaqCM:DCTH
Delcath Systems
|
7.57 | 0% | 0% | 196.44 | 0% | 0% |
NasdaqCM:ASRT
Assertio Holdings
|
1.07 | -,100% | -52.24% | 100.36 | 0% | -35.38% |
NasdaqCM:DRRX
DURECT
|
0.93 | 0% | 0% | 33.21 | 0% | 0% |
NasdaqGS:CPIX
Cumberland Pharmaceuticals
|
2.03 | 0% | 0% | 24.38 | 0% | 0% |
NasdaqGM:ACRX
AcelRx Pharmaceuticals
|
1.08 | 0% | 0% | 17.33 | 0% | 0% |
NasdaqGS:ACOR
Acorda Therapeutics
|
0.43 | 0% | 0% | 0.53 | 0% | 0% |